270 related articles for article (PubMed ID: 20580654)
1. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.
Nikitina-Zake L; Rajalingham R; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2004 Dec; 1037():161-9. PubMed ID: 15699512
[TBL] [Abstract][Full Text] [Related]
4. Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.
Ramos-Lopez E; Scholten F; Aminkeng F; Wild C; Kalhes H; Seidl C; Tonn T; Van der Auwera B; Badenhoop K
Tissue Antigens; 2009 Jun; 73(6):599-603. PubMed ID: 19392800
[TBL] [Abstract][Full Text] [Related]
5. Predominance of the group A killer Ig-like receptor haplotypes in Korean patients with T1D.
Park Y; Choi H; Park H; Park S; Yoo EK; Kim D; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():240-50. PubMed ID: 17130561
[TBL] [Abstract][Full Text] [Related]
6. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
7. Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.
Franceschi DS; Mazini PS; Rudnick CC; Sell AM; Tsuneto LT; de Melo FC; Braga MA; Peixoto PR; Visentainer JE
Tissue Antigens; 2008 Nov; 72(5):478-82. PubMed ID: 18778326
[TBL] [Abstract][Full Text] [Related]
8. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB
Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
[TBL] [Abstract][Full Text] [Related]
9. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between expression of inhibitory killer cell immunoglobulin-like receptor HLA-Cw ligand and susceptibility to inflammatory bowel disease].
Zhang HX; Li JC; Liu ZJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3108-11. PubMed ID: 19159590
[TBL] [Abstract][Full Text] [Related]
11. Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus.
Santin I; de Nanclares GP; Calvo B; Gaafar A; Castaño L; ; Bilbao JR
Hum Immunol; 2006; 67(1-2):118-24. PubMed ID: 16698433
[TBL] [Abstract][Full Text] [Related]
12. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
[TBL] [Abstract][Full Text] [Related]
13. A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.
Jobim M; Jobim LF; Salim PH; Cestari TF; Toresan R; Gil BC; Jobim MR; Wilson TJ; Kruger M; Schlottfeldt J; Schwartsmann G
Tissue Antigens; 2008 Oct; 72(4):392-6. PubMed ID: 18643961
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
15. Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group.
Portela P; Jobim LF; Salim PH; Koff WJ; Wilson TJ; Jobim MR; Schwartsmann G; Roesler R; Jobim M
Int J Immunogenet; 2012 Oct; 39(5):423-8. PubMed ID: 22487023
[TBL] [Abstract][Full Text] [Related]
16. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
17. The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes.
Akesson K; Carlsson A; Ivarsson SA; Johansson C; Weidby BM; Ludvigsson J; Gustavsson B; Lernmark A; Kockum I
Int J Immunogenet; 2009 Feb; 36(1):1-8. PubMed ID: 19055605
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Tissue Antigens; 2014 Nov; 84(5):471-8. PubMed ID: 25329633
[TBL] [Abstract][Full Text] [Related]
19. HLA-C and KIR genes in hepatitis C virus infection.
Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
[TBL] [Abstract][Full Text] [Related]
20. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
